15098-69-8,
Boc-Lys(Boc)-OH.DCHA,
BOC-LYS(BOC)-OH DCHA,
Dicyclohexylamine (S)-2,6-bis((tert-butoxycarbonyl)amino)hexanoate,
Boc-Lys(Boc)-OH dicyclohexammonium salt,
N,N'-Di-Boc-L-lysine dicyclohexylamine salt,
MFCD00038892,
N,N'-Bis(tert-butoxycarbonyl)-L-lysine dicyclohexylamine (1:1),
J-300172,
W-109023,
AK-61225,
EINECS 239-150-9,
Boc-Lys(Boc)-OHCHA,
Boc-Lys(Boc)-OH?CHA,
Boc-Lys(Boc)-OH + DCHA,
Boc-Lys(Boc)-OH . DCHA,
SCHEMBL20547574,
CTK8B7876,
HRLHJTYAMCGERD-MERQFXBCSA-N,
C28H53N3O6,
EBD16900,
KS-00000J1Y,
ANW-58840,
CB-347,
AKOS015924119,
AKOS015950987,
AAA0000938,
AC-8625,
AN-7815,
RTR-006179,
N2,N6-Bis(tert-butoxycarbonyl)-L-lysine, compound with dicyclohexylamine (1:1),
AS-12212,
SC-19224,
AB0011522,
AB1006884,
AX8001915,
di-n-boc-l-lysine dicyclohexylammonium salt,
TL8006189,
FT-0629747,
ST24030318,
K-4799,
098B698,
Nalpha,Nepsilon-Di-Boc-L-lysine Dicyclohexylammonium Salt,
(2S)-2,6-bis[(tert-butoxycarbonyl)amino]hexanoic acid; dicha,
N2,N6-bis(tert-butoxycarbonyl)-L-lysine dicyclohexylamine salt,
dicyclohexylamine (S)-2,6-bis(tert-butoxycarbonylamino)hexanoate,
N-alpha-N-epsilon-di-t-butyloxycarbonyl-L-lysine dicyclohexylamine,
N2,N6-bis(tert-butoxycarbonyl)-L-lysine N-cyclohexylcyclohexanamine,
Nalpha,Nepsilon-Bis(tert-butoxycarbonyl)-L-lysine Dicyclohexylammonium Salt,
(2S)-2,6-bis(tert-butoxycarbonylamino)hexanoic acid; N-cyclohexylcyclohexanamine,
L-Lysine, N2,N6-bis[(1,1-dimethylethoxy)carbonyl]-, compd. with N-cyclohexylcyclohexanamine (1:1),
BOC-LYS(BOC)-OHDCHA,
C16H30N2O6.C12H23N,
ACN-033366,
A7791,
B2178,
Boc-Lys(Boc)-OH.DCHA, 98% - 5G 5g,
C16-H30-N2-O6.C12-H23-N,
N-alpha,e-di-Boc-L-lysine dicyclohexylamine salt,
Boc-Lys(Boc)-OH inverted exclamation mark currencyDCHA,
L-Lysine, N2,N6-bis[(1,1-dimethylethoxy)carbonyl]-, compd. with N-cyclohexylcyclohexanamine (1:1); N,N-Bis-(tert-butoxycarbonyl)-L-lysine dicyclohexylamine salt,